Morphic Holding Inc (NAS:MORF)

$ 56.99 0 (0%) Market Cap: 2.86 Bil Enterprise Value: 2.24 Bil PE Ratio: 0 PB Ratio: 4.62 GF Score: 42/100

Morphic Holding Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Morphic Holding Inc EMERALD-1 Data Results Call Transcript
Oct 12, 2023
Morphic Holding Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2023
Morphic Holding Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Morphic Holding Inc Annual Shareholders Meeting Transcript
Jun 01, 2023
Morphic Holding Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023
Morphic Holding Inc Annual Shareholders Meeting Transcript
Jun 08, 2022
Morphic Holding Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 18, 2022
Q4 2020 Morphic Holding Inc Earnings Call Transcript
Mar 01, 2021

$84.85 (+134.65%)

Earnings
Morphic Holding Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021

Morphic Holding Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 09:30PM GMT

Release Date Price: $30.16 (+0.17%)

Transcript

Gautham Baliga

JP Morgan Chase & Co. - VP of Healthcare Investment Banking

Hello, everyone. Thank you for joining JPMorgan's Annual Healthcare Conference. I'm Gautham Baliga, Vice President in our investment banking team. It's my pleasure to welcome Dr. Praveen Tipirneni, CEO of Morphic Therapeutics, to talk about the company, their exciting programs and the platform.

Before we pass it over to Praveen, I just want to tell the folks that if you want to ask a question, please click on the icon, Ask A Question. Now I hand it over to Praveen to go through the presentation.

Praveen P. Tipirneni

Morphic Holding, Inc. - CEO, President & Director

Great. Well, hi, all. Welcome to Morphic live at the JPMorgan Conference. Thank you to JPMorgan and Phil Ross for inviting us once again to this conference. I'm one of the folks who love this conference. So I'm not happy we're not together in person, and hope that we will -- that will change in future years, but we'll make the best of it here.

We're looking forward to a phenomenal year where we,

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.